GPX4 and cancer: In summary, OIP5-AS1 knockdown promotes ferroptosis and immune evasion in oesophageal cancer through regulation of GPX4, and OIP5-AS1 may serve as a clinical prognostic marker in ferroptosis-based cancer research and immunotherapy.